Trial Profile
Single escalating doses of TMC-310911 +/- ritonavir in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Nov 2013
Price :
$35
*
At a glance
- Drugs TMC 310911 (Primary) ; Ritonavir
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Janssen Infectious Diseases BVBA
- 20 Nov 2013 New trial record
- 10 Oct 2013 Results published in JAIDS.